Psychological and Clinical Factors Associated with Six-Month Glycemic Response During CGM-Supported Care in Insulin-Treated Type 2 Diabetes: A Prospective Real-World Study

Background/Objectives: Clinical and psychological factors associated with glycemic response to continuous glucose monitoring (CGM)-supported care remain incompletely understood in adults with long-standing type 2 diabetes (T2D) receiving intensive insulin therapy. This study examined their associations with six-month glycemic response in routine clinical practice. Methods: This prospective observational study included 225 adults initiating CGM alongside structured education and individualized treatment optimization at a tertiary diabetes center. Composite response was defined as an HbA1c reduction of ≥0.5 percentage points from baseline to six months and/or a time in range (TIR) increase of ≥10 percentage points between months three and six. Exploratory complete-case logistic regression examined clinical characteristics, three-month TIR, and baseline self-efficacy, motivation, and depressive symptoms. Results: Mean age was 66.1 ± 9.0 years, and baseline HbA1c was 8.54 ± 1.86%. The HbA1c response criterion was achieved by 91 of 146 participants (62.3%), and the TIR criterion by 32 of 147 (21.8%). Among 140 participants with evaluable composite outcomes, 97 (69.3%) were responders. Higher baseline HbA1c was associated with composite response (clinical model OR 5.40, 95% CI 2.68–10.88). Self-efficacy, motivation, and depressive symptoms showed no statistically significant associations in the adjusted model. Conclusions: Approximately seven in ten participants with evaluable outcomes achieved a composite glycemic response during CGM-supported care. Higher baseline HbA1c was associated with response, while the psychological measures assessed did not clearly distinguish responders after adjustment. These findings provide insight into response within a structured care pathway for adults with long-standing T2D receiving intensive insulin therapy and warrant confirmation in larger cohorts.

Authors

Institutions

Publication Details

Journal
Healthcare
Published
2026-11-17
DOI
https://doi.org/10.3390/healthcare14223944
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Psychological and Clinical Factors Associated with Six-Month Glycemic Response During CGM-Supported Care in Insulin-Treated Type 2 Diabetes: A Prospective Real-World Study

Daria Sladić Rimac, Ema Schönberger, Miro Bakula, Ines Bilić-Ćurčić et al.
4 links
Healthcare
Diabetes Management and Research
article

Psychological and Clinical Factors Associated with Six-Month Glycemic Response During CGM-Supported Care in Insulin-Treated Type 2 Diabetes: A Prospective Real-World Study

Daria Sladić Rimac, Ema Schönberger, Miro Bakula, Ines Bilić-Ćurčić, Maja Cigrovski Berković, Silvija Canecki-Varžić, Matea Petrinović, Ema Erzic, Klara Dzojic
article en

Abstract

Background/Objectives: Clinical and psychological factors associated with glycemic response to continuous glucose monitoring (CGM)-supported care remain incompletely understood in adults with long-standing type 2 diabetes (T2D) receiving intensive insulin therapy. This study examined their associations with six-month glycemic response in routine clinical practice. Methods: This prospective observational study included 225 adults initiating CGM alongside structured education and individualized treatment optimization at a tertiary diabetes center. Composite response was defined as an HbA1c reduction of ≥0.5 percentage points from baseline to six months and/or a time in range (TIR) increase of ≥10 percentage points between months three and six. Exploratory complete-case logistic regression examined clinical characteristics, three-month TIR, and baseline self-efficacy, motivation, and depressive symptoms. Results: Mean age was 66.1 ± 9.0 years, and baseline HbA1c was 8.54 ± 1.86%. The HbA1c response criterion was achieved by 91 of 146 participants (62.3%), and the TIR criterion by 32 of 147 (21.8%). Among 140 participants with evaluable composite outcomes, 97 (69.3%) were responders. Higher baseline HbA1c was associated with composite response (clinical model OR 5.40, 95% CI 2.68–10.88). Self-efficacy, motivation, and depressive symptoms showed no statistically significant associations in the adjusted model. Conclusions: Approximately seven in ten participants with evaluable outcomes achieved a composite glycemic response during CGM-supported care. Higher baseline HbA1c was associated with response, while the psychological measures assessed did not clearly distinguish responders after adjustment. These findings provide insight into response within a structured care pathway for adults with long-standing T2D receiving intensive insulin therapy and warrant confirmation in larger cohorts.

HealthcareVol. 14(22)
University Hospital Centre Zagreb (HR), University of Zagreb (HR), Klinička bolnica "Sveti Duh" (HR), Catholic University of Croatia (HR), Klinički bolnički centar Osijek (HR), University of Osijek (HR)
Good health and well-being
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon